4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-161508
Director sold 99,613 shares at an average $20.35 ($2,027,158)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kersten Dirk · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-15 | Sale : show line 1 in the form 10b5-1 | −81,840 | $20.27 | $1,659,044 | 4,562,546 | I |
| 2026-04-16 | Sale : show line 2 in the form 10b5-1 | −11,116 | $21.10 | $234,591 | 4,551,430 | I |
| 2026-04-16 | Sale : show line 3 in the form 10b5-1 | −6,657 | $20.06 | $133,523 | 4,544,773 | I |
| Open-market sales · 99,613 sh · avg $20.35 · $2,027,158 | ||||||
Loading xslF345X06/ownership.xml…